Moji Christianah Adeyeye
Biographic Data
| ID | 7581630 |
|---|---|
| NAME | Moji Christianah Adeyeye |
| GIVEN NAMES | Moji Christianah |
| FAMILY NAME | Adeyeye |
| SIGNATURE | ADEYEYE M C |
| AFFILIATIONS | National Agency for Food and Drug Administration and Control , Plot 2032, Olusegun, Obasanjo Way, Zone 7, Wuse, Abuja |
| ORCID | 0000-0003-3808-3166 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
The African Medicines Agency - A potential gamechanger that requires strategic focus
Can public education campaigns equitably counter the use of substandard and falsified medical products in African countries
Substandard and falsified (SF) medical products are a serious health and economic concern that disproportionately impact low- and middle-income countries and marginalized groups. Public education campaigns are demand-side interventions that may reduce the risk of SF exposure, but the effectiveness of such campaigns, and their likelihood of benefitting everybody, is unclear. Nationwide pilot risk communication campaigns, involving multiple media, …
The role of constraints and information gaps in driving risky medicine purchasing practices in four African countries
Substandard and falsified (SF) medical products pose a major threat to public health and socioeconomic development, particularly in low- and middle-income countries. In response, public education campaigns have been developed to alert consumers about the risks of SF medicines and provide guidance on ‘safer’ practices, along with other demand- and supply-side measures. However, little is currently known about the potential effectiveness of such ca…
A qualitative analysis of the Covid-19 vaccination rollout in Lagos, Nigeria
Mass vaccination has proven useful in the control of COVID-19, though vaccine rollout has met major challenges. The learning curve of this process has been valuable. This qualitative study aimed to assess the plan, the process and the progress of the COVID-19 vaccination rollout in Lagos, Nigeria. This study was conducted at vaccination centers in eight of the 20 Local Government Areas in Lagos State from May to July 2021 among healthcare adminis…
No prominent works on this page.
A qualitative analysis of the Covid-19 vaccination rollout in Lagos, Nigeria
Mass vaccination has proven useful in the control of COVID-19, though vaccine rollout has met major challenges. The learning curve of this process has been valuable. This qualitative study aimed to assess the plan, the process and the progress of the COVID-19 vaccination rollout in Lagos, Nigeria. This study was conducted at vaccination centers in eight of the 20 Local Government Areas in Lagos State from May to July 2021 among healthcare adminis…
The role of constraints and information gaps in driving risky medicine purchasing practices in four African countries
Substandard and falsified (SF) medical products pose a major threat to public health and socioeconomic development, particularly in low- and middle-income countries. In response, public education campaigns have been developed to alert consumers about the risks of SF medicines and provide guidance on ‘safer’ practices, along with other demand- and supply-side measures. However, little is currently known about the potential effectiveness of such ca…
The African Medicines Agency - A potential gamechanger that requires strategic focus
Can public education campaigns equitably counter the use of substandard and falsified medical products in African countries
Substandard and falsified (SF) medical products are a serious health and economic concern that disproportionately impact low- and middle-income countries and marginalized groups. Public education campaigns are demand-side interventions that may reduce the risk of SF exposure, but the effectiveness of such campaigns, and their likelihood of benefitting everybody, is unclear. Nationwide pilot risk communication campaigns, involving multiple media, …
Business (4 works) · Medicine (3 works) · Pharmaceutical Economics and Policy (3 works) · Developing country (2 works) · Economic growth (2 works) · Economics (2 works) · Environmental health (2 works) · Intellectual Property and Patents (2 works) · Nursing (2 works) · Pharmaceutical Quality and Counterfeiting (2 works)